<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04008147</url>
  </required_header>
  <id_info>
    <org_study_id>INDIA</org_study_id>
    <nct_id>NCT04008147</nct_id>
  </id_info>
  <brief_title>Hepcidin and Glucose Metabolism</brief_title>
  <official_title>The Effect of Oral Iron Supplements on Hepcidin, Insulin and Glucose Metabolism in Women With Gestational Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swiss Federal Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Women's clinc University Hospital Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Swiss Federal Institute of Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gestational diabetes mellitus (GDM), defined as hyperglycemia with blood glucose values above
      normal but below those diagnostic of DM, and iron deficiency (ID) with or without anemia
      (IDA) are common during pregnancy. Both disease patterns are associated with an increased
      risk of complications during pregnancy and at delivery and may have a variety of negative
      effects on different aspects of child development. Thus, GDM and ID/IDA during pregnancy
      should be prevented.

      Whether iron supplementation with high oral doses acutely increases hepcidin during
      pregnancy, and whether this acute iron-induced increase in hepcidin decreases insulin
      sensitivity, is uncertain.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 3, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum hepcidin</measure>
    <time_frame>before OGTT, 1 day before iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum hepcidin</measure>
    <time_frame>after OGTT, 1 day before iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum hepcidin</measure>
    <time_frame>before OGTT, 1 day after iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum hepcidin</measure>
    <time_frame>after OGTT, 1 day after iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum iron</measure>
    <time_frame>before OGTT, 1 day before iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum iron</measure>
    <time_frame>after OGTT, 1 day before iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum iron</measure>
    <time_frame>before OGTT, 1 day after iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum iron</measure>
    <time_frame>after OGTT, 1 day after iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>glucose</measure>
    <time_frame>before OGTT, 1 day before iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>glucose</measure>
    <time_frame>after OGTT, 1 day before iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>glucose</measure>
    <time_frame>before OGTT, 1 day after iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>glucose</measure>
    <time_frame>after OGTT, 1 day after iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>insulin</measure>
    <time_frame>before OGTT, 1 day before iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>insulin</measure>
    <time_frame>after OGTT, 1 day before iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>insulin</measure>
    <time_frame>before OGTT, 1 day after iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>insulin</measure>
    <time_frame>after OGTT, 1 day after iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum hepcidin</measure>
    <time_frame>7days after iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum iron</measure>
    <time_frame>7days after iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>glucose</measure>
    <time_frame>7days after iron supplementation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>insulin</measure>
    <time_frame>7days after iron supplementation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum ferritin</measure>
    <time_frame>before OGTT, 1 day before iron supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum ferritin</measure>
    <time_frame>after OGTT, 1 day before iron supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum ferritin</measure>
    <time_frame>before OGTT, 1 day after iron supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum ferritin</measure>
    <time_frame>after OGTT, 1 day after iron supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>soluble transferrin receptor</measure>
    <time_frame>before OGTT, 1 day before iron supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>soluble transferrin receptor</measure>
    <time_frame>after OGTT, 1 day before iron supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>soluble transferrin receptor</measure>
    <time_frame>before OGTT, 1 day after iron supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>soluble transferrin receptor</measure>
    <time_frame>after OGTT, 1 day after iron supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>c-reactive protein</measure>
    <time_frame>before OGTT, 1 day before iron supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>c-reactive protein</measure>
    <time_frame>after OGTT, 1 day before iron supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>c-reactive protein</measure>
    <time_frame>before OGTT, 1 day after iron supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>c-reactive protein</measure>
    <time_frame>after OGTT, 1 day after iron supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>alpha glycoprotein</measure>
    <time_frame>before OGTT, 1 day before iron supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>alpha glycoprotein</measure>
    <time_frame>after OGTT, 1 day before iron supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>alpha glycoprotein</measure>
    <time_frame>before OGTT, 1 day after iron supplementation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>alpha glycoprotein</measure>
    <time_frame>after OGTT, 1 day after iron supplementation</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Iron Deficiency Anemia of Pregnancy</condition>
  <condition>Iron Metabolism Disorders</condition>
  <condition>Glucose Intolerance</condition>
  <condition>Gestational Diabetes</condition>
  <arm_group>
    <arm_group_label>No GDM, non-anemic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12 women with no gestational diabetes who are not anemic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No GDM, anemic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>12 women with no gestational diabetes who are anemic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GDM, non anemic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 women with gestational diabetes who are not anemic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GDM, anemic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>12 women with gestational diabetes who are anemic</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>100mg iron sulfate</intervention_name>
    <description>100mg iron sulfate b.i.d. for 4 consecutive days</description>
    <arm_group_label>GDM, anemic</arm_group_label>
    <arm_group_label>GDM, non anemic</arm_group_label>
    <arm_group_label>No GDM, anemic</arm_group_label>
    <arm_group_label>No GDM, non-anemic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  week of pregnancy 24-28

          -  pre-pregnancy BMI &lt;27.5kg/m2

          -  singleton pregnancy

        With either:

          -  GDM and anemia

          -  GDM and no anemia

        OR:

          -  No GDM and anemia

          -  No GDM and no anemia

        Exclusion Criteria:

          -  iron infusion within the past 6 months

          -  severely anemic Hb&lt;8.0g/dl

          -  acute or chronic disease

          -  long-term medication

          -  smoking
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnancy</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicole U Stoffel, PhD</last_name>
    <phone>+41 44 632 83 93</phone>
    <email>nicole.stoffel@hest.ethz.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Human Nutrition Laboratory ETH Zurich</name>
      <address>
        <city>Zürich</city>
        <zip>8092</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole U Stoffel, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 1, 2019</study_first_submitted>
  <study_first_submitted_qc>July 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2019</study_first_posted>
  <last_update_submitted>July 15, 2019</last_update_submitted>
  <last_update_submitted_qc>July 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Swiss Federal Institute of Technology</investigator_affiliation>
    <investigator_full_name>Nicole Stoffel</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
    <mesh_term>Iron Metabolism Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

